Company Overview of Orchestra Therapeutics, Inc.
On April 12, 2012, Orchestra Therapeutics, Inc, went out of business as per its Chapter 7 liquidation filing under bankruptcy. Orchestra Therapeutics, Inc., an immuno-pharmaceutical company, focuses on the development of various products to treat autoimmune and infectious diseases. It offers NeuroVax, an immune-based therapeutic product, which is based on T-cell receptor peptide technology for the treatment of multiple sclerosis. NeuroVax is in Phase II clinical trails. The company, formerly known as The Immune Response Corporation, was founded in 1986 and changed its name to Orchestra Therapeutics, Inc. in April 2007. Orchestra Therapeutics, Inc. is headquartered in Carlsbad, California.
5931 Darwin Court
Carlsbad, CA 92008
Founded in 1986
Key Executives for Orchestra Therapeutics, Inc.
Orchestra Therapeutics, Inc. does not have any Key Executives recorded.
Similar Private Companies By Industry
|20n Labs, Inc.||United States|
|23andMe, Inc.||United States|
|2C Tech Corporation, Inc.||United States|
|3-V Biosciences, Inc.||United States|
|3D Bio Holdings LLC||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|NYC2012, Inc.||United States|
|Rush University||United States|
|Bloomberg L.P.||United States|
Sponsored Financial Commentaries
To contact Orchestra Therapeutics, Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.